Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy
Author:
Funder
National Institutes of Health
NCI
Publisher
Elsevier BV
Subject
Surgery
Reference23 articles.
1. Adjuvant capecitabine for breast cancer after preoperative chemotherapy;Masuda;N Engl J Med,2017
2. Trastuzumab Emtansine for residual invasive HER2-positive breast cancer;von Minckwitz;N Engl J Med,2019
3. Axillary management after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer;Kantor;Ann Surg Oncol,2021
4. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients;Yau;Lancet Oncol,2022
5. The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer;Spanheimer;Am J Surg,2013
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2024-09-04
2. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer;Annals of Surgical Oncology;2024-07-24
3. Prediction of the number of positive axillary lymph nodes according to sentinel lymph node involvement and biological subtypes in patients receiving neoadjuvant chemotherapy;BMC Surgery;2024-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3